Literature DB >> 30999147

Successful outcome after Pancreaticodoudenectomy in an elderly cirrhotic patient: A case report.

Eraj Sahaab1, Nadeem Iqbal2, Abu Bakar Hafeez Bhatti3.   

Abstract

INTRODUCTION: Cirrhosis is a risk factor for poor outcomes in non-hepatic oncological resections. There are only a handful of cases demonstrating outcomes of pancreaticoduodenectomy (PD) in patients with pancreatic cancer and underlying cirrhosis. Moreover, pushing the limits of PD to elderly cirrhotic patients and demonstrating its safety remains under reported. CASE
PRESENTATION: Here, we report successful management of a 71 year-old-lady with HCV related liver cirrhosis, obstructive jaundice and poor performance status, who was medically optimized and then underwent PD for adenocarcinoma of the head of pancreas. There was no major post-operative morbidity except minor chyle leak which resolved spontaneously. On her last follow up, she was doing well and undergoing adjuvant chemotherapy. DISCUSSION: Preoperative medical optimization and careful patient selection can yield successful outcomes even after a major abdominal surgery like PD in elderly patients with underlying liver cirrhosis.
CONCLUSION: Liver cirrhosis is not a contra indication to PD in elderly patients with good performance status.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Child Pugh Score; Liver cirrhosis; Morbidity; Whipple's procedure

Year:  2019        PMID: 30999147      PMCID: PMC6468143          DOI: 10.1016/j.ijscr.2019.03.034

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


Introduction

Surgical resection remains the only curative option for patients with resectable pancreatic adenocarcinoma. Presence of liver cirrhosis increases the risk of adverse post operative outcomes [1,2]. Old age and MELD score is an important risk factor for post-operative morbidity and mortality in these patients [3]. There is lack of data on the safety of PD in elderly cirrhotic patients. The model for end stage liver disease (MELD) has not been incorporated in majority of available literature on PD in cirrhotics. Moreover, assessment of liver failure in these patients who are otherwise at risk of hyperbilirubinemia and deranged coagulation profile due to obstructive jaundice remains unclear. Here, the authors have reported successful outcome after PD in a 71-year-old cirrhotic patient with diagnosis of adenocarcinoma of the head of the pancreas. The current work has been reported in line with the SCARE criteria [4].

Case Study

A 71 year-old-lady with past history of hepatitis C virus (HCV) related cirrhosis was referred to the surgical clinic for obstructive jaundice. Her associated complaints included abdominal pain along with intermittent high grade fever. There were no co-morbids and no past surgical history. At the time of her presentation, her BMI was 21 kg/m2 and performance status (Eastern co operative oncology group (ECOG score) was 3). A CT scan with pancreatic protocol confirmed the presence of resectable pancreatic tumor. She was discussed in the multi disciplinary team meeting and was referred for endoscopic retrograde cholangiopancreatography (ERCP), endoscopic ultrasound(EUS) and HCV treatment followed by surgical resection if feasible. She underwent ERCP and stenting twice. Endoscopic ultrasound guided biopsy of pancreatic lesion was performed which showed atypical glandular proliferation suspicious of adenocarcinoma. Since a period of 4–6 weeks is recommended between ERCP and surgery, she was also started on direct acting anti virals due to high viral load. Her labs before and after biliary drainage and HCV treatment are shown in Table 1.
Table 1

Biochemical profile and functional status before and after biliary drainage and HCV treatment.

Before Biliary drainage4 weeks Post Biliary drainage
Total Bilirubin13.8 mg/dl1.2 mg/dl
Direct Bilirubin9.3 mg/dl0.8 mg/dl
AST91 U/L45 U/L
ALT57 U/L30 U/L
Alkaline Phosphatase157 U/L103 U/L
GGT140 U/L161 U/L
Serum Albumin2.93.1
INR1.21.2
MELD NA239
CTP scoreB (8)A (6)
ECOG status31
Biochemical profile and functional status before and after biliary drainage and HCV treatment. Due to marked improvement in health, she was offered PD. Intra operatively, she had macro nodular liver cirrhosis (Fig. 1). She underwent PD with peri portal lymphadenectomy as shown in Fig. 2. A Roux loop was fashioned and end to side duct to mucosa pancreaticojejunostomy was performed with PDS 6/0. Intra operative blood loss was 200 ml. Operative time was 6 h. Post operative ICU stay was 4 days. She received Imipenem and Vancomycin for 5 days in the post operative period. Nasojejunal feeding was started on post operative day 2 while oral feed was resumed on day 3. Day 4 drain amylase was 9 U/L and 12 U/L. Her liver function tests and coagulation profile was performed daily for 3 days and was within normal range. The patient had a minor chyle leak which settled on its own with fat free diet. Due to underlying cirrhosis, the patient was kept on low salt diet and fluid restriction. The patient was discharged on 6th post operative day. The histopathology of resected specimen showed moderately differentiated pancreatic ductal adenocarcinoma (pT3N1) with peri neural and lymphovascular invasion. All margins were negative and one lymph node was positive for metastasis. The patient remains in good health three months after surgery and is receiving adjuvant chemotherapy at this time.
Fig. 1

Macro nodular cirrhosis in HCV +ve patient undergoing pancreaticodoudenectomy.

Fig. 2

After specimen retrieval and portal lymphadenectomy. Note a replaced right hepatic artery from superior mesenteric artery.

Macro nodular cirrhosis in HCV +ve patient undergoing pancreaticodoudenectomy. After specimen retrieval and portal lymphadenectomy. Note a replaced right hepatic artery from superior mesenteric artery.

Discussion

Liver cirrhosis significantly increases the peri-operative morbidity and mortality following major surgeries [[1], [2], [3]]. In particular, safety of PD in cirrhotic patients has not been fully demonstrated. Moreover, the impact of old age in such patients has not been exclusively studied and reported. There is limited literature on outcomes of PD in cirrhotic patients. These studies have used Child Turcot Pugh (CTP) score for assessment of liver failure and MELD score has not been utilized. Busquets and colleagues compared 15 patients with CTP A cirrhosis with a control group of 30 non-cirrhotic patients undergoing PD. Morbidity rate in cirrhotics was high (73%) [5]. It was not possible to determine if patients aged >70 years underwent PD in the cirrhotic group. It was also not shown whether degree of liver failure was assessed before or after biliary drainage. In another comparative study, El Nakeeb and colleagues showed increased operative time, blood loss, morbidity and mortality in cirrhotic patients. The study showed increased risk of bleeding in patients with liver cirrhosis (53.7% cirrhotics had blood loss >500 ml) [6]. They used a cut off of 10 mg/dl for biliary drainage. Around 37.3% cirrhotic patients did not have pre operative ERCP. This could have resulted in erroneous elevation of CTP scores. In our case, patient's MELD score dropped from 23 to 9 and CTP score from B(8) to A(6) after biliary drainage. This was associated with concomitant improvement in ECOG score. The patient had been denied surgical intervention elsewhere due to high MELD and CTP score and poor ECOG. This was however, falsely elevated due to obstructive jaundice. It is important that in these patients a low threshold for ERCP is kept since biliary drainage improves CTP and MELD score and overall health of the patient. It has been shown that in cirrhotic patients, a single point increase in MELD score above 8 increases post operative mortality by 15% [3]. It has also been shown that age >70 years adds 3 points to the MELD score. Based on this assumption, our patient had a 60% mortality risk in the post operative period. The successful outcome in the current case was possible owing to careful pre-operative planning. It can be argued that in the presence of poor prognostic factors like cirrhosis, age >70 and MELD >8 and ECOG of 3; a non surgical palliative approach should have been considered in this patient. However excellent response to preoperative optimization with normalization of LFTs and improvement in ECOG after biliary drainage and HCV treatment signified possibility of a favorable outcome in this patient. It has been shown that high volume centers can have acceptable outcomes after PD even in challenging scenarios [7,8]. The authors believe that a high volume center, meticulous attention to surgical detail with minimal intra-operative blood loss, careful patient selection, use of broad spectrum antibiotics, salt and fluid restriction to prevent exacerbation of liver failure and simultaneous existence of an experienced liver transplant program [8] are some of the factors that had a positive impact on post-operative outcomes. We believe that routine total bilirubin cut off of 10 mg/dl should not be used in cirrhotic patients for biliary drainage since high bilirubin many a times is not because of liver failure but biliary obstruction. Attention to surgical detail, tailored post- operative care with focus on infection control, preemptive management of liver failure and early mobilization and initiation of enteral feeding might produce outcomes comparable to non-cirrhotic patients undergoing PD.

Conclusion

Liver cirrhosis should not be considered an absolute contraindication to PD. Pre-operative optimization in patients with low grade liver failure yielding good performance status produces acceptable outcomes even in elderly patients. Aggressive preoperative biliary drainage in the preoperative period and pre emptive management of liver failure post operatively improves outcomes after PD in cirrhotics.

Conflict of interest

None of the authors have any conflicts of interests.

Funding

No funding source.

Ethical approval

This is a single case report and did not need ethical approval from hospital ethics committee.

Consent

The patient gave informed consent fof the details of this case to be shared for academic purpose.

Author contribution

Eraj Sahaab: concept, writing, critical review. Nadeem Iqbal: Writing, critical review. Abu Bakar Hafeez Bhatti: concept, writing, review.

Registration of research studies

Not a first-in-man. Single case report. Registration not required.

Guarantor

Abu bakar Hafeez Bhatti.

Provenance and peer review

Not commissioned, externally peer-reviewed.
  7 in total

1.  The SCARE 2018 statement: Updating consensus Surgical CAse REport (SCARE) guidelines.

Authors:  Riaz A Agha; Mimi R Borrelli; Reem Farwana; Kiron Koshy; Alexander J Fowler; Dennis P Orgill
Journal:  Int J Surg       Date:  2018-10-18       Impact factor: 6.071

2.  Risk factors for mortality after surgery in patients with cirrhosis.

Authors:  Swee H Teh; David M Nagorney; Susanna R Stevens; Kenneth P Offord; Terry M Therneau; David J Plevak; Jayant A Talwalkar; W Ray Kim; Patrick S Kamath
Journal:  Gastroenterology       Date:  2007-01-25       Impact factor: 22.682

3.  Living Donor Liver Transplantation in South Asia: Single Center Experience on Intermediate-Term Outcomes.

Authors:  Faisal S Dar; Abu Bakar H Bhatti; Ammal I Qureshi; Nusrat Y Khan; Zahaan Eswani; Haseeb H Zia; Eitzaz U Khan; Nasir A Khan; Atif Rana; Najmul H Shah; Mohammad Salih; Rashid Nazer
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

4.  Survival advantage with para aortic lymphadenectomy in peri-ampullary cancer: A retrospective cohort study.

Authors:  Abu Bakar Hafeez Bhatti; Faisal Saud Dar; Eraj Sahaab; Nusrat Yar Khan; Haseeb Zia; Atif Rana; Muhammad Salih; Najmul Hassan Shah
Journal:  Int J Surg       Date:  2016-06-01       Impact factor: 6.071

5.  Impact of cirrhosis on surgical outcome after pancreaticoduodenectomy.

Authors:  Ayman El Nakeeb; Ahmad M Sultan; Tarek Salah; Mohamed El Hemaly; Emad Hamdy; Ali Salem; Ahmed Moneer; Rami Said; Ahmed AbuEleneen; Mostafa Abu Zeid; Talaat Abdallah; Mohamed Abdel Wahab
Journal:  World J Gastroenterol       Date:  2013-11-07       Impact factor: 5.742

6.  Is pancreaticoduodenectomy a safe procedure in the cirrhotic patient?

Authors:  Juli Busquets; Núria Peláez; Marta Gil; Lluís Secanella; Emilio Ramos; Laura Lladó; Joan Fabregat
Journal:  Cir Esp       Date:  2016-04-01       Impact factor: 1.653

Review 7.  Cancer and liver cirrhosis: implications on prognosis and management.

Authors:  Matthias Pinter; Michael Trauner; Markus Peck-Radosavljevic; Wolfgang Sieghart
Journal:  ESMO Open       Date:  2016-03-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.